InvestorsHub Logo
Followers 1192
Posts 9766
Boards Moderated 0
Alias Born 03/30/2010

Re: None

Tuesday, 02/12/2019 7:33:34 PM

Tuesday, February 12, 2019 7:33:34 PM

Post# of 55

"As medical marijuana regulations ease, Feldmann is paving the way for a new class of cannabis derived-drugs to treat pain and other conditions. His background and expertise will be valuable as we accelerate growth in the medical marijuana pharmaceutical space and capitalize on the industry's evolution," says Alex Somjen, President & CEO of Resinco.



From recent PR

$RSCZF